Dodge & Cox Portfolio holdings
Dodge & Cox, founded in 1930 by Van Duyn Dodge and E. Morris Cox in San Francisco, California, is an independent, employee-owned investment management firm renowned for its disciplined, value-oriented approach to long-term investing. Managing over $350 billion in assets as of late 2024, the firm offers a concise lineup of mutual funds and separate accounts focusing on U.S. and international equities, fixed income, and balanced portfolios, serving individual and institutional investors with a low-turnover, research-driven strategy. Known for its team-based decision-making and contrarian stance—buying undervalued securities others overlook—Dodge & Cox has maintained a consistent philosophy through decades, avoiding trend-chasing and emphasizing fundamentals, even during market volatility like the 2008 crisis. With a tight-knit team of about 300 employees and no proprietary trading, the firm’s commitment to simplicity, low fees, and client alignment has earned it a loyal following and a reputation as a steadfast player in asset management.
Top Buys
| 1 |
GSK
GSK
|
$1.04B |
| 2 |
Comcast
CMCSA
|
$699M |
| 3 |
Medtronic
MDT
|
$496M |
| 4 |
JNPR
Juniper Networks
JNPR
|
$460M |
| 5 |
Johnson Controls International
JCI
|
$416M |
Top Sells
| 1 |
Walmart
WMT
|
$1.48B |
| 2 |
VMW
VMware, Inc
VMW
|
$760M |
| 3 |
Bank of America
BAC
|
$670M |
| 4 |
HP
HPQ
|
$652M |
| 5 |
Goldman Sachs
GS
|
$581M |
Sector Composition
| 1 | Financials | 24.98% |
| 2 | Healthcare | 19.53% |
| 3 | Communication Services | 15.87% |
| 4 | Technology | 14.22% |
| 5 | Energy | 6.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
MetLife
MET
$54.1B
| $2.01B | 1.55% | 39,698,537 +16,647 | +0% | +$842K |
|
27
AstraZeneca
AZN
$248B
| $1.96B | 1.52% | 56,530,979 +330,801 | +0.6% | +$11.5M |
|
|
TWX
28
DELISTED
Time Warner Inc
TWX
| $1.91B | 1.48% | 20,884,431 -2,808,338 | -12% | -$257M |
|
29
Union Pacific
UNP
$133B
| $1.81B | 1.4% | 13,481,579 -135,790 | -1% | -$18.2M |
|
30
Bristol-Myers Squibb
BMY
$96B
| $1.78B | 1.38% | 29,106,111 +51,150 | +0.2% | +$3.13M |
|
|
31
HP
HPQ
$26.7B
| $1.77B | 1.37% | 84,240,797 -31,029,880 | -27% | -$652M |
|
32
Eli Lilly
LLY
$657B
| $1.7B | 1.32% | 20,181,287 +161,210 | +0.8% | +$13.6M |
|
|
33
GSK
GSK
$79.9B
| $1.56B | 1.21% | 44,083,293 +29,225,156 | +197% | +$1.04B |
|
34
Suncor Energy
SU
$50.1B
| $1.51B | 1.17% | 41,068,900 +832,700 | +2% | +$30.6M |
|
|
35
Medtronic
MDT
$119B
| $1.48B | 1.14% | 18,284,758 +6,137,663 | +51% | +$496M |
|
36
Booking.com
BKNG
$181B
| $1.33B | 1.03% | 764,035 +9,572 | +1% | +$16.6M |
|
37
APA Corp
APA
$8.31B
| $1.32B | 1.03% | 31,343,245 +1,404,266 | +5% | +$59.3M |
|
38
Target
TGT
$43.6B
| $1.31B | 1.01% | 20,069,301 -194,716 | -1% | -$12.7M |
|
39
Liberty Global Class C
LBTYK
$4.07B
| $1.27B | 0.98% | 37,545,905 +2,004,800 | +6% | +$67.8M |
|
|
MFGP
40
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
| $1.23B | 0.95% | 36,591,316 -69,790 | -0.2% | -$2.34M |
|
41
Celanese
CE
$5.22B
| $1.17B | 0.91% | 10,962,170 -517,999 | -5% | -$55.5M |
|
42
Dell
DELL
$82.6B
| $1.16B | 0.9% | 14,279,005 +4,244,741 | +42% | +$345M |
|
43
JD.com
JD
$44.1B
| $1.15B | 0.89% | 27,711,291 -1,896,900 | -6% | -$78.6M |
|
44
Baidu
BIDU
$32.8B
| $1.13B | 0.87% | 4,817,587 -73,000 | -1% | -$17.1M |
|
45
NOV
NOV
$4.94B
| $1.12B | 0.87% | 31,174,239 -8,327 | -0% | -$300K |
|
46
Gilead Sciences
GILD
$140B
| $1.1B | 0.86% | 15,416,361 +5,506,630 | +56% | +$394M |
|
47
Alnylam Pharmaceuticals
ALNY
$58.5B
| $1.05B | 0.81% | 8,231,595 -909,900 | -10% | -$116M |
|
|
JNPR
48
DELISTED
Juniper Networks
JNPR
| $1.03B | 0.8% | 36,092,857 +16,144,100 | +81% | +$460M |
|
49
Baker Hughes
BKR
$44.8B
| $1.03B | 0.79% | 32,428,460 +8,630,089 | +36% | +$273M |
|
50
Truist Financial
TFC
$60.4B
| $987M | 0.76% | 19,841,938 -764,546 | -4% | -$38M |
|